Cabergoline
Brand: Cabaser
Endocrine
Dopamine agonist
Chemistry
| PubChem |
CID: 54746 |
Structure
Pharmacokinetics
| Half-life | 65 hours |
| Clearance Route | hepatic |
| Active Metabolites | uncertain |
⚠️ Safety & Warnings
Severity: Moderate
Adverse Effects:
Nausea, dizziness, hypotension
Contraindications:
Uncontrolled hypertension
Precautions:
Start low dose, monitor BP